LFVN Quote, Financials, Valuation and Earnings

Arcadia Biosciences, Inc. has a net margin of 0.56% compared to LifeVantage Corp.'s net margin of 65.75%. LifeVantage Corp.'s return on equity of 23.86% beat Arcadia Biosciences, Inc.'s return on equity of -71.48%.

LifeVantage Corp. has a consensus price target of $8.00, signalling upside risk potential of 54.14%. On the other hand Arcadia Biosciences, Inc. has an analysts' consensus of $12.00 which suggests that it could grow by 566.67%. Given that Arcadia Biosciences, Inc. has higher upside potential than LifeVantage Corp., analysts believe Arcadia Biosciences, Inc. is more attractive than LifeVantage Corp..

LifeVantage Corp. has a beta of 0.356, which suggesting that the stock is 64.382% less volatile than S&P 500. In comparison Arcadia Biosciences, Inc. has a beta of 0.573, suggesting its less volatile than the S&P 500 by 42.67%.

LifeVantage Corp. has a quarterly dividend of $0.05 per share corresponding to a yield of 3.47%. Arcadia Biosciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeVantage Corp. pays 21.85% of its earnings as a dividend. Arcadia Biosciences, Inc. pays out -- of its earnings as a dividend. LifeVantage Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LifeVantage Corp. quarterly revenues are $48.9M, which are larger than Arcadia Biosciences, Inc. quarterly revenues of $1.3M. LifeVantage Corp.'s net income of $276K is lower than Arcadia Biosciences, Inc.'s net income of $856K. Notably, LifeVantage Corp.'s price-to-earnings ratio is 8.67x while Arcadia Biosciences, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeVantage Corp. is 0.32x versus 0.48x for Arcadia Biosciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

RegalWorks Media, Inc. has a net margin of 0.56% compared to LifeVantage Corp.'s net margin of -821.05%. LifeVantage Corp.'s return on equity of 23.86% beat RegalWorks Media, Inc.'s return on equity of -7.77%.

LifeVantage Corp. has a consensus price target of $8.00, signalling upside risk potential of 54.14%. On the other hand RegalWorks Media, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that LifeVantage Corp. has higher upside potential than RegalWorks Media, Inc., analysts believe LifeVantage Corp. is more attractive than RegalWorks Media, Inc..

LifeVantage Corp. has a beta of 0.356, which suggesting that the stock is 64.382% less volatile than S&P 500. In comparison RegalWorks Media, Inc. has a beta of -1.039, suggesting its less volatile than the S&P 500 by 203.853%.

LifeVantage Corp. has a quarterly dividend of $0.05 per share corresponding to a yield of 3.47%. RegalWorks Media, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeVantage Corp. pays 21.85% of its earnings as a dividend. RegalWorks Media, Inc. pays out -- of its earnings as a dividend. LifeVantage Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LifeVantage Corp. quarterly revenues are $48.9M, which are larger than RegalWorks Media, Inc. quarterly revenues of $1.9K. LifeVantage Corp.'s net income of $276K is higher than RegalWorks Media, Inc.'s net income of -$15.6K. Notably, LifeVantage Corp.'s price-to-earnings ratio is 8.67x while RegalWorks Media, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeVantage Corp. is 0.32x versus 1,022.51x for RegalWorks Media, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Spectrum Brands Holdings, Inc. has a net margin of 0.56% compared to LifeVantage Corp.'s net margin of 4.34%. LifeVantage Corp.'s return on equity of 23.86% beat Spectrum Brands Holdings, Inc.'s return on equity of 5.46%.

LifeVantage Corp. has a consensus price target of $8.00, signalling upside risk potential of 54.14%. On the other hand Spectrum Brands Holdings, Inc. has an analysts' consensus of $85.29 which suggests that it could grow by 15.69%. Given that LifeVantage Corp. has higher upside potential than Spectrum Brands Holdings, Inc., analysts believe LifeVantage Corp. is more attractive than Spectrum Brands Holdings, Inc..

LifeVantage Corp. has a beta of 0.356, which suggesting that the stock is 64.382% less volatile than S&P 500. In comparison Spectrum Brands Holdings, Inc. has a beta of 0.639, suggesting its less volatile than the S&P 500 by 36.137%.

LifeVantage Corp. has a quarterly dividend of $0.05 per share corresponding to a yield of 3.47%. Spectrum Brands Holdings, Inc. offers a yield of 2.55% to investors and pays a quarterly dividend of $0.47 per share. LifeVantage Corp. pays 21.85% of its earnings as a dividend. Spectrum Brands Holdings, Inc. pays out 48.84% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

LifeVantage Corp. quarterly revenues are $48.9M, which are smaller than Spectrum Brands Holdings, Inc. quarterly revenues of $677M. LifeVantage Corp.'s net income of $276K is lower than Spectrum Brands Holdings, Inc.'s net income of $29.4M. Notably, LifeVantage Corp.'s price-to-earnings ratio is 8.67x while Spectrum Brands Holdings, Inc.'s PE ratio is 17.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeVantage Corp. is 0.32x versus 0.66x for Spectrum Brands Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

USANA Health Sciences, Inc. has a net margin of 0.56% compared to LifeVantage Corp.'s net margin of -0.71%. LifeVantage Corp.'s return on equity of 23.86% beat USANA Health Sciences, Inc.'s return on equity of 1.96%.

LifeVantage Corp. has a consensus price target of $8.00, signalling upside risk potential of 54.14%. On the other hand USANA Health Sciences, Inc. has an analysts' consensus of $39.00 which suggests that it could grow by 124.91%. Given that USANA Health Sciences, Inc. has higher upside potential than LifeVantage Corp., analysts believe USANA Health Sciences, Inc. is more attractive than LifeVantage Corp..

LifeVantage Corp. has a beta of 0.356, which suggesting that the stock is 64.382% less volatile than S&P 500. In comparison USANA Health Sciences, Inc. has a beta of 0.642, suggesting its less volatile than the S&P 500 by 35.795%.

LifeVantage Corp. has a quarterly dividend of $0.05 per share corresponding to a yield of 3.47%. USANA Health Sciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeVantage Corp. pays 21.85% of its earnings as a dividend. USANA Health Sciences, Inc. pays out -- of its earnings as a dividend. LifeVantage Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LifeVantage Corp. quarterly revenues are $48.9M, which are smaller than USANA Health Sciences, Inc. quarterly revenues of $226.2M. LifeVantage Corp.'s net income of $276K is higher than USANA Health Sciences, Inc.'s net income of -$1.6M. Notably, LifeVantage Corp.'s price-to-earnings ratio is 8.67x while USANA Health Sciences, Inc.'s PE ratio is 30.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeVantage Corp. is 0.32x versus 0.35x for USANA Health Sciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.